admin

State FDA’s commanded by DCGI on Sugam portals update

State FDA’s Commanded by DCGI on Sugam Portals Update

The Drugs Controller General of India (DCGI) has instructed state drug regulators to take necessary action and direct all the manufacturers on how to upload their manufacturing sites and formulation data on Sugam portal which will strengthen the drug regulatory system by way of improving the transparency, accountability as well as accessibility of the drugs in the country.

State FDA’s Commanded by DCGI on Sugam Portals Update Read More »

Govt designs new principle to get patients remuneration for damaged medical devices

Govt designs a new principle to get patients remuneration for faulty medical devices

The government is planning to introduce amendments to the Drugs and Cosmetics Act, 1940 which will provide compensation to patients if they are sold a faulty medical device by a manufacturer or importer. The decision has been taken in the backdrop of the uproar caused earlier this year in India and abroad over defective hip

Govt designs a new principle to get patients remuneration for faulty medical devices Read More »

Final Guidance On Medical Device Benefit And Risk Analysis For 510K

Final guidance on medical device benefit and risk analysis for 510(k)s being approved by FDA

Medical Device Benefit And Risk Analysis For 510(k)s In association with the safety and efficacy of the applicant’s device, the FDA will consider “any credible benefit to health from the use of the device against any potential risk of trauma or illness from such use, among other applicable factors.” The FDA recently released final guidance

Final guidance on medical device benefit and risk analysis for 510(k)s being approved by FDA Read More »

Scroll to Top